Skip to content

Multicenter cohort study of radiofrequency ablation for metastatic liver tumor

Multicenter cohort study of radiofrequency ablation for metastatic liver tumor - Multicenter cohort study of radiofrequency ablation for metastatic liver tumor

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000014807
Enrollment
100
Registered
2014-08-09
Start date
2014-05-14
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metastatic liver tumor

Interventions

None listed

Sponsors

Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with metastatic liver tumor who were treated by radiofrequency ablation.

Exclusion criteria

Exclusion criteria: Patients whom the physicians in charge judge their enrollment inappropriate.

Design outcomes

Primary

MeasureTime frame
Overall survival Recurrence-free survival

Countries

Japan

Contacts

Public ContactKazuki Maesaka

Osaka University Graduate School of Medicine Department of Gastroenterology and Hepatology

k.maesaka@gh.med.osaka-u.ac.jp+81-6-6879-3621

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026